Stay updated on A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 implemented. - Previous revision: v3.4.3 removed. - No visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-03-20T00:22:17.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. No substantive content changes observed.
    Difference
    0.1%
    Check dated 2026-03-12T20:39:38.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed on the page, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:17:35.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision history updated: Revision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T00:55:05.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated study record metadata to include 'Last Update Submitted that Met QC Criteria' and a new revision label (Revision: v3.4.0). Removed or reformatted older QC-related text such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'.
    Difference
    0.2%
    Check dated 2026-01-28T21:15:48.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The page revision was updated from v3.3.3 to v3.3.4, with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:16:30.000Z thumbnail image

Stay in the know with updates to A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.